Primary hyperparathyroidism

Steven Rodgers, John Lew, Carmen C. Solórzano

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: This article reviews the diagnosis and treatment of primary hyperparathyroidism, including recent literature on the subject. RECENT FINDINGS: Important recent advancements in the field of parathyroid disease include improvements in preoperative localization, the use of intraoperative parathyroid hormone monitoring, and the development of minimally invasive and videoscopic surgical techniques. Additionally, there has been significant interest in better understanding the clinical changes and presentation of sporadic primary hyperparathyroidism, including the assessment of neurocognitive symptoms before and after surgery. This has led to a change in the definition of the 'asymptomatic patient' and altered the criteria used to trigger surgical intervention. SUMMARY: Although the cause of primary hyperparathyroidism is still poorly understood, surgical parathyroidectomy results in long-term cure in greater than 95% of cases. Improvements in our understanding of this disease continue to make diagnosis and treatment safer and more effective.

Original languageEnglish
Pages (from-to)52-58
Number of pages7
JournalCurrent Opinion in Oncology
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Primary Hyperparathyroidism
Parathyroid Diseases
Parathyroidectomy
Symptom Assessment
Parathyroid Hormone
Therapeutics

Keywords

  • Adenoma
  • Hyperparathyroidism
  • Multigland disease
  • Parathyroid
  • Parathyroid hormone

ASJC Scopus subject areas

  • Cancer Research

Cite this

Primary hyperparathyroidism. / Rodgers, Steven; Lew, John; Solórzano, Carmen C.

In: Current Opinion in Oncology, Vol. 20, No. 1, 01.01.2008, p. 52-58.

Research output: Contribution to journalArticle

Rodgers, Steven ; Lew, John ; Solórzano, Carmen C. / Primary hyperparathyroidism. In: Current Opinion in Oncology. 2008 ; Vol. 20, No. 1. pp. 52-58.
@article{c08751d968224d98967951d59dd1aeb9,
title = "Primary hyperparathyroidism",
abstract = "PURPOSE OF REVIEW: This article reviews the diagnosis and treatment of primary hyperparathyroidism, including recent literature on the subject. RECENT FINDINGS: Important recent advancements in the field of parathyroid disease include improvements in preoperative localization, the use of intraoperative parathyroid hormone monitoring, and the development of minimally invasive and videoscopic surgical techniques. Additionally, there has been significant interest in better understanding the clinical changes and presentation of sporadic primary hyperparathyroidism, including the assessment of neurocognitive symptoms before and after surgery. This has led to a change in the definition of the 'asymptomatic patient' and altered the criteria used to trigger surgical intervention. SUMMARY: Although the cause of primary hyperparathyroidism is still poorly understood, surgical parathyroidectomy results in long-term cure in greater than 95{\%} of cases. Improvements in our understanding of this disease continue to make diagnosis and treatment safer and more effective.",
keywords = "Adenoma, Hyperparathyroidism, Multigland disease, Parathyroid, Parathyroid hormone",
author = "Steven Rodgers and John Lew and Sol{\'o}rzano, {Carmen C.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1097/CCO.0b013e3282f2838f",
language = "English",
volume = "20",
pages = "52--58",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Primary hyperparathyroidism

AU - Rodgers, Steven

AU - Lew, John

AU - Solórzano, Carmen C.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - PURPOSE OF REVIEW: This article reviews the diagnosis and treatment of primary hyperparathyroidism, including recent literature on the subject. RECENT FINDINGS: Important recent advancements in the field of parathyroid disease include improvements in preoperative localization, the use of intraoperative parathyroid hormone monitoring, and the development of minimally invasive and videoscopic surgical techniques. Additionally, there has been significant interest in better understanding the clinical changes and presentation of sporadic primary hyperparathyroidism, including the assessment of neurocognitive symptoms before and after surgery. This has led to a change in the definition of the 'asymptomatic patient' and altered the criteria used to trigger surgical intervention. SUMMARY: Although the cause of primary hyperparathyroidism is still poorly understood, surgical parathyroidectomy results in long-term cure in greater than 95% of cases. Improvements in our understanding of this disease continue to make diagnosis and treatment safer and more effective.

AB - PURPOSE OF REVIEW: This article reviews the diagnosis and treatment of primary hyperparathyroidism, including recent literature on the subject. RECENT FINDINGS: Important recent advancements in the field of parathyroid disease include improvements in preoperative localization, the use of intraoperative parathyroid hormone monitoring, and the development of minimally invasive and videoscopic surgical techniques. Additionally, there has been significant interest in better understanding the clinical changes and presentation of sporadic primary hyperparathyroidism, including the assessment of neurocognitive symptoms before and after surgery. This has led to a change in the definition of the 'asymptomatic patient' and altered the criteria used to trigger surgical intervention. SUMMARY: Although the cause of primary hyperparathyroidism is still poorly understood, surgical parathyroidectomy results in long-term cure in greater than 95% of cases. Improvements in our understanding of this disease continue to make diagnosis and treatment safer and more effective.

KW - Adenoma

KW - Hyperparathyroidism

KW - Multigland disease

KW - Parathyroid

KW - Parathyroid hormone

UR - http://www.scopus.com/inward/record.url?scp=36549056174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549056174&partnerID=8YFLogxK

U2 - 10.1097/CCO.0b013e3282f2838f

DO - 10.1097/CCO.0b013e3282f2838f

M3 - Article

C2 - 18043256

AN - SCOPUS:36549056174

VL - 20

SP - 52

EP - 58

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 1

ER -